Nutex Health (NASDAQ:NUTX) Stock Price Expected to Rise, Lake Street Capital Analyst Says

Key Points

• Lake Street Capital raised its Nutex Health price target to $333 from $310 and maintained a Buy rating, implying 71.5% upside from the prior close.
• Analyst views are generally positive but not unanimous: MarketBeat reports a Moderate Buy consensus and an average price target of $342, with four Buy ratings and one Hold.
• Nutex Health’s latest quarterly results topped estimates, reporting EPS of $5.71 versus $5.54 expected and revenue of $217.61 million versus $214.82 million expected.

Nutex Health (NASDAQ:NUTX - Get Free Report) had its price target boosted by Lake Street Capital from $310.00 to $333.00 in a report released on Monday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Lake Street Capital's price target suggests a potential upside of 71.51% from the stock's previous close.

A number of other research firms also recently weighed in on NUTX. Weiss Ratings upgraded Nutex Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, October 6th. B. Riley Financial upped their price objective on Nutex Health from $325.00 to $357.00 and gave the stock a "buy" rating in a research note on Monday. LADENBURG THALM/SH SH began coverage on Nutex Health in a report on Monday, October 26th. They issued a "buy" rating and a $336.00 price objective for the company. Zacks Research downgraded Nutex Health from a "strong-buy" rating to a "hold" rating in a report on Tuesday, October 6th. Finally, Wall Street Zen cut shares of Nutex Health from a "buy" rating to a "hold" rating in a research note on Saturday, October 31st. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, Nutex Health has an average rating of "Moderate Buy" and a consensus price target of $342.00.

Nutex Health Stock Up 7.5%

Shares of Nutex Health stock traded up $13.60 during trading hours on Monday, reaching $194.16. 153,906 shares of the company's stock were exchanged, compared to its average volume of 167,001. The company has a 50 day moving average of $203.11 and a two-hundred day moving average of $151.38. Nutex Health has a fifty-two week low of $83.99 and a fifty-two week high of $226.16. The company has a current ratio of 5.00, a quick ratio of 4.96 and a debt-to-equity ratio of 0.59. The stock has a market cap of $1.33 billion, a P/E ratio of 8.29 and a beta of 0.66.

Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.54 by $0.17. Nutex Health had a return on equity of 35.99% and a net margin of 20.68%. The business had revenue of $217.61 million for the quarter, compared to the consensus estimate of $214.82 million. On average, sell-side analysts forecast that Nutex Health will post 26.65 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Scott Saunders sold 203 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the sale, the director owned 400 shares in the company, valued at approximately $85,700. This represents a 33.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 44.68% of the company's stock.

Hedge Funds Weigh In On Nutex Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUTX. Kilter Group LLC acquired a new stake in Nutex Health during the 2nd quarter worth approximately $27,000. Allworth Financial LP bought a new stake in Nutex Health in the 2nd quarter valued at $35,000. GK Wealth Management LLC bought a new stake in Nutex Health in the 3rd quarter valued at $73,000. EverSource Wealth Advisors LLC bought a new stake in Nutex Health in the 1st quarter valued at $83,000. Finally, State of Alaska Department of Revenue grew its holdings in Nutex Health by 243.6% in the 3rd quarter. State of Alaska Department of Revenue now owns 1,000 shares of the company's stock valued at $211,000 after buying an additional 709 shares in the last quarter. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health, Inc NASDAQ: NUTX is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.